Cookie Notice

This site uses cookies. By continuing to browse this site, you are agreeing to our use of cookies. Review our cookies information for more details.

OK
MENU
Back to Top

Abstract Topics

 

Abstract Topics

  • Active, Positive and Successful Ageing
  • Age-friendly environments
  • Agitation 
  • AI- Artificial intelligence
  • Behavior 
  • Behavioral and Psychological Symptoms of Dementia (BPSD) 
  • Biological Markers 
  • Capacity 
  • Caregiving
  • Chronic Disease 
  • Clinical Trials: (involving elders in research – PPI) 
  • Cognition
  • COVID-19 
  • Cultural/Regional Issues 
  • Curriculum Development/Training in Old Age
  • Delirium 
  • Dementia  
    • Alzheimer’s Disease  
    • Frontotemporal
    • Lewy Body disease 
    • Multi-infarct (vascular) 
    • Mild cognitive impairment 
    • Early Onset 
    • Other 
  • Depression 
  • Diagnostic Methods 
    • Brain Imaging 
    • Neurocognitive Assessment 
      • Biomarkers
  • Psychiatric Disorders  
    • Anxiety
    • Psychotic 
    • Personality 
    • Mood
    • Sleep 
    • Other 
  • Early Career  
  • Education 
    • Health Care Professionals 
    • Public 
    • Consumer 
    • Other 
  • Emotion Processing
  • Burnout, compassion fatigues and elder care 
  • Ethical/Legal Issues 
  • Frailty
  • Genetics 
  • Governance and Regulation 
  • Home Care 
  • Human Rights 
  • Iatrogeny
  • Late Career Transition and Retirement
  • Long Term Care 
  • Loneliness
  • Mental Healthcare  
    • Case finding, early detection 
    • Prevention 
    • Pro-active approach and community care
    • Integrative and combined approach 
    • Technology/Innovation
  • Molecular Biology 
  • Multi-Disciplinary Team 
  • Needs
  • Nursing 
  • Nutrition 
  • Occupational Therapy
  • Palliative Care (including End of Life Care)
    • Advance care planning 
  • Parkinson’s disease 
  • Patients with Disabilities 
  • Pharmacoeconomics 
  • Polypharmacy and Drug Interactions 
  • Psychological and Social Health 
  • Psychosocial Interactions/Social well-being 
  • Quality of Life 
  • Schizophrenia
  • Service Delivery: Focus on community setting 
  • Sexuality 
  • Social Networks/Community 
  • Substance Abuse 
  • Suicide
  • Technology 
  • Teleconsultation
  • Treatment 
    • Non-pharmacological 
    • Alternative 
    • Arts 
    • Cognitive Behavioral
    • Family/Group 
    • Psychotherapy  
    • Pharmacological 
  • Other (please specify)

Acknowledgements

Acadia Pharmaceuticals Axsome Cambridge University Press Cerevel Lundbeck Otsuka